Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ARNA

Arena Pharmaceuticals (ARNA) Stock Price, News & Analysis

Arena Pharmaceuticals logo

About Arena Pharmaceuticals Stock (NASDAQ:ARNA)

Advanced Chart

Key Stats

Today's Range
$99.99
$99.99
50-Day Range
$93.13
$99.99
52-Week Range
$45.50
$100.00
Volume
107 shs
Average Volume
1.56 million shs
Market Capitalization
$6.17 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ARNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Arena Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

ARNA Stock News Headlines

Arwana Citramulia Tbk (ARNA)
Buffett’s $325 Billion Cash Problem — Solved by Gold?
A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most investors are still asleep… but not for long. Garrett Goggin’s latest research reveals how you can “front-run” the greatest investor alive by positioning in four small miners sitting on up to 100X potential upside. When this hits the news — it’ll be too late.
RNA startup launches with $300M, Merck partnership
Arna L. Davidson
See More Headlines

ARNA Stock Analysis - Frequently Asked Questions

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) issued its quarterly earnings data on Thursday, November, 4th. The biopharmaceutical company reported ($3.21) earnings per share for the quarter, missing the consensus estimate of ($2.53) by $0.68.

Arena Pharmaceuticals's stock reverse split on the morning of Monday, June 19th 2017.The 1-10 reverse split was announced on Wednesday, June 14th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Friday, June 16th 2017. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Arena Pharmaceuticals investors own include Advanced Micro Devices (AMD), NVIDIA (NVDA), Meta Platforms (META), Cytokinetics (CYTK), Micron Technology (MU), Bristol Myers Squibb (BMY) and Canopy Growth (CGC).

Company Calendar

Last Earnings
11/04/2021
Today
7/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:ARNA
CIK
1080709
Employees
448
Year Founded
1977

Profitability

EPS (Trailing Twelve Months)
($10.13)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$616.43 million
Net Margins
N/A
Pretax Margin
-1,141,542.63%
Return on Equity
-69.83%
Return on Assets
-62.35%

Debt

Debt-to-Equity Ratio
0.05
Current Ratio
8.59
Quick Ratio
8.59

Sales & Book Value

Annual Sales
$50 thousand
Price / Sales
123,305.67
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$10.94 per share
Price / Book
9.14

Miscellaneous

Outstanding Shares
61,659,000
Free Float
60,173,000
Market Cap
$6.17 billion
Optionable
Optionable
Beta
0.55

Social Links

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:ARNA) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners